1.Expression of p21(waf1/cip1) Protein in Bladder Cancer and its Prognostic Value.
Hwal LEE ; Houng Gyu SOHN ; Dal Bong HA ; Ki Kwon KIM ; Kyung Seop LEE
Korean Journal of Urology 2000;41(7):826-832
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
2.T1 bladder tumor: a heterogeneous and potentially dangerous group.
Journal of the Korean Cancer Association 1991;23(4):843-852
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
3.Intravesical Therapy for Superficial Bladder Cancer: Advances and Future.
Korean Journal of Urology 2000;41(4):467-479
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
4.The Direct Anti-Cancer Effect of a Single Instillation of Epirubicin after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer.
Yu Seob SHIN ; Ji Yong KIM ; Oh Seok KO ; A Ram DOO ; Myung Ki KIM ; Young Beom JEONG ; Hyung Jin KIM
Korean Journal of Urology 2012;53(2):78-81
PURPOSE: To evaluate the direct anti-cancer effect of a single instillation of epirubicin (SIE) after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC) by analysis of immediate urine cytology (IUC). MATERIALS AND METHODS: We reviewed the records of 158 patients who had IUC after TURBT for NMIBC. Fifty-six patients were treated with SIE after TURBT and 102 patients were not treated with SIE. The direct anti-cancer effect of SIE was compared in the two groups according to the result of IUC. The relationship between SIE and IUC in NMIBC was analyzed by use of multivariate Cox proportional hazards regression models. RESULTS: The IUC-positive rate was 33.9% in the SIE group and 42.1% in the non-SIE group (p=0.005). The IUC-positive rate was lower in the SIE group than in the non-SIE group for each factor, including tumor stage, tumor grade, tumor size, tumor multiplicity, and preoperative urine cytology. Multivariate Cox proportional hazards regression analysis revealed that SIE was significantly associated with a negative IUC result in patients with NMIBC (HR, 0.163) (p<0.001). CONCLUSIONS: These results indicate the direct anti-cancer effect of SIE in patients who undergo TURBT for NMIBC.
Epirubicin
;
Humans
;
Urinary Bladder
;
Urinary Bladder Neoplasms
5.Comparison of the Bard BTA stat test, Bard BTA test, NMP-22 test and Cytology in the Diagnosis of Bladder Cancer.
Jeong Soo KIM ; Hyun Mu LEE ; Kang Hyun LEE
Korean Journal of Urology 2000;41(7):833-837
No abstract available.
Diagnosis*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
6.Intrathecal Phenol Saddle Block in Bladder Cancer Patients: Two case reports.
Sun Joon CHO ; Jin Woo SHIN ; Seung Hye SUNG ; Hong Gi MIN ; Jun Gol SONG ; Jeong Gil LIM ; Chung LEE
Korean Journal of Anesthesiology 2006;50(3):351-354
We encountered two bladder cancer patients who suffered from perineal pain that was intractable despite the use of adjuvant medication. A phenol intrathecal (saddle) block was performed without any specific complications. The results were excellent and allowed the systemic opiate dose to be reduced by more than 80%. We report our clinical experience, including a brief review of the relevant literature.
Humans
;
Phenol*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
7.Prognostic indexes in patients treated with intravesical bacillus calmette-guerin for superficial bladder cancer.
Choal Hee PARK ; Chun Il KIM ; Sung Choon LEE
Journal of the Korean Cancer Association 1991;23(4):835-842
No abstract available.
Bacillus*
;
Humans
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
8.Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8).
Kwang Joon KIM ; Sun Ok SONG ; Byung Wan LEE
Diabetes & Metabolism Journal 2013;37(1):83-84
No abstract available.
Thiazolidinediones
;
Urinary Bladder
;
Urinary Bladder Neoplasms
10.Mitomycin C vs. bacillus calmette-guerin: comparison of prophylactic efficacy to high risk superficial bladder tumor.
Eun Sik LEE ; Moon Soo PARK ; Chongwook LEE
Journal of the Korean Cancer Association 1991;23(1):101-106
No abstract available.
Bacillus*
;
Mitomycin*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
Result Analysis
Print
Save
E-mail